| AC-DC, ac/dc | alternating current or direct current |
|---|---|
| CC | calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card... |
| CS | calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ... |
| ADC | adult day care [facility]; affective disorders clinic; Aid to [Families with] Dependent Children; AI... |
| ADLAR | advanced design linear accelerator radiosurgery |
| CAD | Computer Aided Design |
|---|---|
| PBS | Pharmaceutical Benefits Scheme |
| AC | Alternating current |
| Isc | Baseline short-circuit current |
| CCC | Counter-current chromatography |
dough
| chemistry, pharmaceutical | Chemistry that deals with the composition and preparation of substances used in treatment of patients or diagnostic studies. (12 Dec 1998) |
|---|---|
| pharmaceutical | 1. Pertaining to pharmacy or to drugs. 2. <pharmacology> A medicinal drug. (18 Nov 1997) |
| pharmaceutical biology | <pharmacology, study> A subfield of pharmacology which studies natural drugs, including the study of their biological and chemical components, botanical sources, and other characteristics (economic, biochemical, biological, etc.). (09 Oct 1997) |
| pharmaceutical chemistry | Medicinal chemistry in its application to the analysis, development, preparation, and the manufacture of drugs. Synonym: medicinal chemistry, pharmacochemistry. (05 Mar 2000) |
| pharmaceutical preparations | Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. (12 Dec 1998) |
| pharmaceutical services | Total pharmaceutical services provided by a qualified pharmacist. In addition to the preparation and distribution of medical products, they may include consultative services provided to agencies and institutions which do not have a qualified pharmacist. (12 Dec 1998) |
| pharmaceutical solutions | Homogeneous liquid preparations that contain one or more chemical substances dissolved, i.e., molecularly dispersed, in a suitable solvent or mixture of mutually miscible solvents. For reasons of their ingredients, method of preparation, or use, they do not fall into another group of products. (12 Dec 1998) |
| preservatives, pharmaceutical | Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include antibiotics and antioxidants. (12 Dec 1998) |
| societies, pharmaceutical | Societies whose membership is limited to pharmacists. (12 Dec 1998) |
| insurance, pharmaceutical services | Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products. (12 Dec 1998) |
| technology, pharmaceutical | The application of scientific knowledge or technology to pharmacy, pharmacology, and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures and in the treatment of patients. (12 Dec 1998) |
| economics, pharmaceutical | Economic aspects of the fields of pharmacy and pharmacology as they apply to the development and study of medical economics in rational drug therapy and the impact of pharmaceuticals on the cost of medical care. Pharmaceutical economics also includes the economic considerations of the pharmaceutical care delivery system and in drug prescribing, particularly of cost-benefit values. (12 Dec 1998) |
| fees, pharmaceutical | Amounts charged to the patient or third-party payer for medication. It includes the pharmacist's professional fee and cost of ingredients, containers, etc. (12 Dec 1998) |
| block design test | A performance test using coloured blocks which the individual must use to match pictured designs; one of the subtests of the Wechsler intelligence scales. (05 Mar 2000) |
| rational drug design | <pharmacology> Modeling the molecular structure of the target of a drug, for example, an antigen, and then designing a drug that will attack it. (17 Dec 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|